Lovelace Biomedical Talks About Developing Novel Therapies for Cystic Fibrosis Month
May is Cystic Fibrosis (CF) month. Lovelace has been working in respiratory research for over 70 years, and has been using gene therapy...
Phages, Viruses that Attack Bacteria, Are a Potential Therapy Against Infections, Case Report Sugges
The case report of a cystic fibrosis (CF) patient suggests that phages — viruses that naturally infect and kill bacteria — are a...
SNSP113 (Previously SYGN113)
SNSP113 is an inhaled therapy being developed by Synspira Therapeutics that aims to ease pulmonary infections, airway congestion, and...
Incidence of CF-related Diabetes Stable in Pediatric CF, Canadian Study Finds
The incidence rate of cystic fibrosis-related diabetes (CFRD) in children with cystic fibrosis (CF) has remained stable over time,...
Phage viruses tailored in Pitt lab used to treat patient with drug-resistant infection Phage viruses
A cocktail of viruses developed at the University of Pittsburgh to precisely attack life-threatening bacteria resistant to antibiotics...
Early, Rapid BMI Increase May Affect Overall Growth of CF Children, Study Suggests
Rapid weight gain early in life may have a long-term negative impact on the growth of children with cystic fibrosis (CF), a study has...